by tjackson | Nov 1, 2019 | Uncategorized
The Preclinical Testing Core (PTC) of the MODEL-AD) consortium supports preclinical screening of test compounds nominated by the greater research community. The PTC has established a streamlined preclinical drug testing strategy with go/no-go decision points that...
by tjackson | Sep 5, 2019 | Uncategorized
Monday, October 21, 2019 Session #354 – 4:15-4:30 PM – McCormick Place: Room S103 Title: Developing mouse models to study late-onset Alzheimer’s Disease D. BAGLIETTO-VARGAS1,2, L. CAI1, M. NGUYEN1, K. HUYNH1, A.C. MARTINI1, L. TRUJILLO-ESTRADA1, C. SOTO3, I....
by tjackson | Jun 27, 2019 | Uncategorized
Sunday, July 14, 4:55-5:15 PM, Petree Hall C #F1-07-03 Alzheimer’s Susceptibility Genes Implicate Microglial Activity Julie Williams, PhD1,2; Rebecca Sims, PhD3; Philip Taylor, PhD2; Michael Sasner, PhD4; Harriet M Williams, MPhil4 and Gareth Howell, PhD3,4, (1)UK...
by tjackson | Jun 27, 2019 | Uncategorized
Preuss C, Pandey R, Piazza E, Fine A, Uyar A, Perumal T, Garceau D, Kotredes KP, Williams H, Mangravite LM, Lamb BT, Oblak AL, Howell GR, Sasner M, Logsdon BA, Carter GW. A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease....
by tjackson | Feb 28, 2019 | Uncategorized
A gene expression-based screening platform for mouse models of late-onset Alzheimer’s disease When: Thursday, March 14, 9:00 a.m. PT Speaker: Greg Carter, PhD, Associate Professor, The Jackson Laboratory Late-onset Alzheimer’s disease (LOAD) is the most common...
by tjackson | Feb 4, 2019 | Uncategorized
In Mukherjee et al, we provide a generalizable framework for integration of diverse systems biology outputs to rank and identify new transcriptomic and genetic drivers of Alzheimer’s disease. This provides evidence that integration of multiple systems biology...
